Tourmaline Bio, Inc.
Biotechnology company · New York, United States
Tourmaline Bio, Inc. is a biotechnology company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $115 million sold in a notice filed in 2020.
Profile compiled from public records. Is this your company? Request a correction or update
Tourmaline Bio at a glance
Typebiotechnology company
HeadquartersNew York, United States
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1827506
What does Tourmaline Bio do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $115 million sold (2020).
Frequently asked questions about Tourmaline Bio
Where is Tourmaline Bio headquartered?
Tourmaline Bio, Inc. is headquartered in New York, United States.
What does Tourmaline Bio do?
Tourmaline Bio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences